PBMCs, or peripheral blood mononuclear cells, are immune cells collected from the bloodstream that share one defining feature: they each have a single, round nucleus. This group includes lymphocytes (T cells, B cells, and natural killer cells) and monocytes. They are distinct from red blood cells, which have no nucleus, and from granulocytes like neutrophils, which have multi-lobed nuclei. PBMCs are one of the most widely used cell preparations in immunology research because they give scientists a living snapshot of a person’s immune system from a simple blood draw.
Cell Types Inside a PBMC Sample
A purified PBMC sample is not one cell type but a mix of several. Lymphocytes typically make up 70% to 90% of the total, with monocytes accounting for most of the remainder. Within that lymphocyte fraction, T cells are the largest group, generally representing 45% to 70% of all PBMCs. B cells usually make up 5% to 15%, and natural killer (NK) cells contribute roughly 5% to 20%. Monocytes, the larger cells in the mix, typically account for 10% to 30%.
Each of these cell types plays a different role. T cells coordinate and carry out targeted immune attacks. B cells produce antibodies. NK cells specialize in killing virus-infected cells and certain tumor cells without needing prior exposure. Monocytes are versatile cells that can engulf pathogens directly and later mature into macrophages or dendritic cells in tissues. A small number of dendritic cells also appear in PBMC preparations, though their proportion is typically under 2%.
How PBMCs Are Isolated From Blood
PBMCs are separated from whole blood using a technique called density gradient centrifugation. The most common version uses a product called Ficoll-Paque, a dense sugar solution. Blood is carefully layered on top of this solution in a tube, then spun in a centrifuge. Because different blood components have different densities, they settle into distinct layers during spinning.
Red blood cells and granulocytes are heavier and sink to the bottom. Plasma rises to the top. PBMCs, which are lighter than red blood cells but heavier than plasma, collect in a visible band between the two layers. Researchers can then carefully pipette off this band, wash the cells, and use them for experiments. The whole process takes roughly 30 to 45 minutes and yields a relatively pure population of mononuclear cells from just a few milliliters of blood.
PBMCs vs. the Buffy Coat
You may see the term “buffy coat” used alongside PBMCs, and the two are related but not identical. When whole blood is centrifuged without a density gradient medium, a thin whitish layer forms between the red blood cells and plasma. This is the buffy coat, and it contains PBMCs plus granulocytes (mainly neutrophils) and platelets. A PBMC preparation is a more refined version of the buffy coat, with those granulocytes and platelets largely removed by the density gradient step. The result is a cleaner sample focused on lymphocytes and monocytes.
Normal PBMC Counts in Healthy Adults
In a healthy adult, PBMC counts in peripheral blood typically fall in a reference range of about 0.1 to 0.6 × 10⁹ per liter. To put that in practical terms, a single milliliter of blood generally yields somewhere between 0.5 and 3 million PBMCs, though this varies with age, health status, time of day, and individual differences. Researchers planning experiments need to account for this variability when deciding how much blood to collect from donors.
Why PBMCs Matter in Research
PBMCs are a workhorse of immunology because they let researchers study living human immune cells without an invasive biopsy. They have been widely employed to assess many aspects of immune regulation. Common experiments include measuring how quickly immune cells multiply in response to a challenge (proliferation assays), identifying which signaling molecules the cells release (cytokine profiling), and tracking changes in gene activity.
Cytokine secretion is one of the most commonly measured outcomes. When PBMCs are stimulated in the lab, T cells and monocytes release specific signaling proteins that reveal whether the immune response is tilting toward fighting bacteria, combating parasites, or calming inflammation. This information helps researchers evaluate everything from how a new drug affects immune function to whether a probiotic strain has genuine immune-modulating properties. Studies have used PBMCs to assess the immunomodulatory effects of probiotic bacteria, food-derived compounds, and pharmaceutical agents alike.
In vaccine development, PBMCs collected before and after vaccination show whether a candidate vaccine is actually triggering the intended immune response. In cancer immunotherapy, PBMCs from patients can be tested to see how well their immune cells recognize and kill tumor cells. And in infectious disease research, PBMC samples taken during and after infection reveal how the immune system responded over time.
What PBMCs Reveal About Disease
Because PBMCs reflect the state of the circulating immune system, shifts in their composition can signal disease activity. In the autoimmune skin condition bullous pemphigoid, for example, patients show significantly lower counts of certain T cells and B cells in their blood compared to healthy individuals, while a specific type of monocyte involved in tissue repair increases dramatically. Researchers believe the drop in some cell types may not mean those cells have disappeared. Instead, they may have migrated out of the blood and into inflamed tissue, which is why their numbers drop in circulation.
This principle applies across many conditions. In infections, cancers, and autoimmune diseases, the balance of cell types within PBMCs shifts in characteristic patterns. Tracking these changes over time gives clinicians and researchers a window into how a disease is progressing or how well a treatment is working, all from a routine blood sample.
How PBMCs Are Stored for Later Use
Freshly isolated PBMCs are ideal, but many studies require samples collected weeks, months, or even years apart. Cryopreservation (controlled freezing) makes this possible. The standard approach involves suspending PBMCs in a freezing solution containing 10% DMSO, a cryoprotectant that prevents ice crystals from destroying cells during freezing. The tubes are then placed in a minus 80°C freezer for short-term storage or transferred to liquid nitrogen (minus 196°C) for long-term banking.
Thawing technique matters significantly for cell survival. Rapid thawing in a 37°C water bath, followed by washing in pre-warmed culture medium, yields the best results. One study comparing thawing protocols found that washing cells with medium heated to 37°C produced a mean viability of nearly 97%, while using cold medium at 4°C dropped viability to about 81% and cut the number of recovered live cells substantially. After thawing, PBMCs can rest in an incubator for up to about eight hours without losing viability, but leaving them for 16 hours or longer causes a noticeable decline in both cell counts and health.
These storage and recovery details are not trivial. For studies comparing immune responses across time points, like before and after treatment, poor cryopreservation can introduce artifacts that have nothing to do with biology and everything to do with handling. Standardized freezing and thawing protocols are essential for reliable results.